(Q40678720)

22 September 2017

title

Role of specific cytochrome P450 enzymes in the N-oxidation of the antiarrhythmic agent mexiletine (English)

1 reference

22 September 2017

Labbé L

1

1 reference

22 September 2017

Abolfathi Z

2

1 reference

22 September 2017

Lessard E

3

1 reference

22 September 2017

Pakdel H

4

1 reference

22 September 2017

Beaune P

5

1 reference

22 September 2017

Turgeon J

6

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

22 September 2017

1 reference

22 September 2017

volume

33

1 reference

22 September 2017

issue

1

1 reference

22 September 2017

page(s)

13-25

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000017948

22 September 2017

1 reference

Comparison of procainamide and mexiletine in prevention of ventricular arrhythmias after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000017948

Stereoselective disposition of mexiletine in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000017948

Kinetics and bioavailability of mexiletine in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000017948

Predicting the hepatic clearance of xenobiotics in humans from in vitro data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000017948

Mexiletine effects on theophylline disposition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000017948

The specificity of inhibition of debrisoquine 4-hydroxylase activity by quinidine and quinine in the rat is the inverse of that in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000017948

Effect of fluvoxamine on the pharmacokinetics of mexiletine in healthy Japanese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000017948

Involvement of CYP1A2 in mexiletine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000017948

A form of cytochrome P450 in man, orthologous to form d in the rat, catalyses the O-deethylation of phenacetin and is inducible by cigarette smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000017948

Fluvoxamine is a potent inhibitor of cytochrome P4501A2

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000017948

Effect of cigarette smoking on mexiletine kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000017948

Influence of mexiletine on caffeine elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000017948

Inhibition of theophylline metabolism by mexiletine in young male and female nonsmokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000017948

Effect of rifampicin treatment on the kinetics of mexiletine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000017948

Influence of mexiletine on the pharmacokinetics of theophylline in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000017948

Purification and characterization of six cytochrome P-450 isozymes from human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000017948

10.1080/0049825021000017948

21 January 2018

Identifiers

DOI

1 reference

22 September 2017

1 reference